Poly Medicure Limited has submitted a regulatory filing to both BSE Limited and National Stock Exchange of India Limited intimating them of a scheduled investor/analyst meeting pursuant to Regulation 30 and applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Schedule III Part A.
The company's officials will hold a one-on-one meeting with analysts/investors with the following specific details:
- Meeting Participant: Trust AMC
- Meeting Date: Wednesday, 17th June 2026
- Meeting Time: 10:30 AM India Time
- Meeting Venue: Plant visit at Plot No. 117, HSIIDC Industrial Area, Sector-59, Faridabad-121004, India
- Meeting Format: One-on-one meeting
The company has explicitly stated that no Unpublished Price Sensitive Information will be shared during the meeting. The schedule is subject to changes which may occur due to exigencies on the part of the Analysts/Investors or the Company. This information is also available on the company's website at www.polymedicure.com.
The document was digitally signed by Avinash Chandra, Company Secretary (Membership No. A32270), on June 12, 2026, at 16:30:59 IST.